| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cell adhesion molecule binding | SPTAN1 SPTBN2 EXOC3 EVPL ACTN4 SIRPA ACTN3 ITGA2B ITGAD ADAM8 SVEP1 STAT1 NLGN2 PLEC DMD UTRN VCL SFN FERMT3 APC LAMA5 NLGN1 LCP1 YWHAB TSPAN8 MACF1 | 1.22e-10 | 599 | 191 | 26 | GO:0050839 |
| GeneOntologyMolecularFunction | integrin binding | ACTN4 ACTN3 ITGA2B ITGAD ADAM8 SVEP1 DMD UTRN FERMT3 LAMA5 LCP1 TSPAN8 | 1.25e-07 | 175 | 191 | 12 | GO:0005178 |
| GeneOntologyMolecularFunction | actin binding | MYH6 MYO10 SPTAN1 SPTBN2 ACTN4 ACTN3 SPTBN5 FBXO25 PPP1R9B PLEC DMD UTRN VCL LRRC10 TRIOBP LCP1 PPP1R18 MACF1 CROCC | 1.85e-07 | 479 | 191 | 19 | GO:0003779 |
| GeneOntologyMolecularFunction | actin filament binding | MYH6 MYO10 SPTAN1 SPTBN2 ACTN4 ACTN3 SPTBN5 PPP1R9B PLEC VCL TRIOBP LCP1 MACF1 | 3.01e-07 | 227 | 191 | 13 | GO:0051015 |
| GeneOntologyMolecularFunction | benzodiazepine receptor binding | 8.49e-06 | 5 | 191 | 3 | GO:0030156 | |
| GeneOntologyMolecularFunction | phosphatase binding | SIRPA STAT1 STAT3 PPP1R9B CACNA1B ANK1 DTNA CPD PPP1R18 AKAP1 MTMR9 | 4.97e-05 | 264 | 191 | 11 | GO:0019902 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | DLG5 MYH6 MYO10 SPTAN1 SPTBN2 ACTN4 ACTN3 SPTBN5 FBXO25 STARD9 PPP1R9B PLEC DMD UTRN VCL ANK1 LRRC10 APC TRIOBP APOE LCP1 PPP1R18 MACF1 CROCC AKAP1 | 5.13e-05 | 1099 | 191 | 25 | GO:0008092 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | TBC1D19 AGAP5 ACAP1 RAPGEF5 CYTH2 SIRPA AGAP11 AGAP4 AGAP3 ARHGAP23 DENND1A AKAP13 AGAP9 AGAP7P AGAP6 | 1.14e-04 | 507 | 191 | 15 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | TBC1D19 AGAP5 ACAP1 RAPGEF5 CYTH2 SIRPA AGAP11 AGAP4 AGAP3 ARHGAP23 DENND1A AKAP13 AGAP9 AGAP7P AGAP6 | 1.14e-04 | 507 | 191 | 15 | GO:0030695 |
| GeneOntologyMolecularFunction | dystroglycan binding | 1.78e-04 | 12 | 191 | 3 | GO:0002162 | |
| GeneOntologyMolecularFunction | dipeptidyl-peptidase activity | 1.78e-04 | 12 | 191 | 3 | GO:0008239 | |
| GeneOntologyMolecularFunction | protein phosphatase binding | 1.96e-04 | 210 | 191 | 9 | GO:0019903 | |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 2.57e-04 | 130 | 191 | 7 | GO:0005200 | |
| GeneOntologyMolecularFunction | spectrin binding | 3.01e-04 | 34 | 191 | 4 | GO:0030507 | |
| GeneOntologyMolecularFunction | GTPase activator activity | TBC1D19 AGAP5 ACAP1 AGAP11 AGAP4 AGAP3 ARHGAP23 AGAP9 AGAP7P AGAP6 | 3.68e-04 | 279 | 191 | 10 | GO:0005096 |
| GeneOntologyMolecularFunction | cadherin binding | 4.39e-04 | 339 | 191 | 11 | GO:0045296 | |
| GeneOntologyMolecularFunction | lipid binding | AGAP5 MYO10 CYTH2 SPTBN2 AGAP11 STARD9 AGAP4 FCHSD1 FERMT3 CYP26B1 RBP3 APOE DENND1A NR2F2 SYT8 TLR1 RORA ZFYVE26 AGAP9 AGAP7P AGAP6 | 5.24e-04 | 988 | 191 | 21 | GO:0008289 |
| GeneOntologyMolecularFunction | very-low-density lipoprotein particle receptor binding | 5.39e-04 | 4 | 191 | 2 | GO:0070326 | |
| GeneOntologyMolecularFunction | GTPase binding | KNTC1 NCKAP1 RASIP1 VCL DMXL2 TRIOBP LCP1 DENND1A AKAP13 TNPO3 XPOT | 7.23e-04 | 360 | 191 | 11 | GO:0051020 |
| GeneOntologyMolecularFunction | intracellularly calcium-gated channel activity | 8.71e-04 | 20 | 191 | 3 | GO:0141147 | |
| GeneOntologyMolecularFunction | intracellularly calcium-gated chloride channel activity | 8.71e-04 | 20 | 191 | 3 | GO:0005229 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | TBC1D19 AGAP5 ACAP1 RAPGEF5 CYTH2 SIRPA AGAP11 GTF3C4 BMP2 NOD1 CCNL1 PPP1R9B AGAP4 SFN AGAP3 ARHGAP23 KDM5A APC APOE YWHAB DENND1A AKAP13 AGAP9 AGAP7P AGAP6 MTMR9 | 1.05e-03 | 1418 | 191 | 26 | GO:0030234 |
| GeneOntologyMolecularFunction | small GTPase binding | KNTC1 NCKAP1 RASIP1 VCL DMXL2 TRIOBP DENND1A AKAP13 TNPO3 XPOT | 1.09e-03 | 321 | 191 | 10 | GO:0031267 |
| GeneOntologyBiologicalProcess | cell-matrix adhesion | SIRPA ACTN3 ITGA2B ITGAD ADAM8 SVEP1 STRC DMD UTRN VCL STRCP1 FERMT3 ADAMTS12 MACF1 | 2.54e-07 | 270 | 192 | 14 | GO:0007160 |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | ACTN4 SIRPA ACTN3 ITGA2B ITGAD ADAM8 SVEP1 STRC DMD UTRN VCL STRCP1 FERMT3 TRIOBP LAMA5 ADAMTS12 MACF1 | 3.15e-07 | 410 | 192 | 17 | GO:0031589 |
| GeneOntologyBiologicalProcess | neuromuscular synaptic transmission | 9.29e-07 | 36 | 192 | 6 | GO:0007274 | |
| GeneOntologyCellularComponent | actin cytoskeleton | KNTC1 MYH6 NCKAP1 MYO10 SPTAN1 SPTBN2 ACTN4 ACTN3 ADAM8 SPTBN5 PPP1R9B VCL FCHSD1 FERMT3 TRIOBP LCP1 MACF1 AKAP13 CROCC | 1.90e-06 | 576 | 194 | 19 | GO:0015629 |
| GeneOntologyCellularComponent | cortical actin cytoskeleton | 2.47e-06 | 93 | 194 | 8 | GO:0030864 | |
| GeneOntologyCellularComponent | cortical cytoskeleton | 3.33e-06 | 129 | 194 | 9 | GO:0030863 | |
| GeneOntologyCellularComponent | cell cortex | MYO10 SPTAN1 SPTBN2 EXOC3 ACTN4 ACTN3 SPTBN5 PPP1R9B FCHSD1 ANK1 APC MACF1 AKAP13 | 4.59e-05 | 371 | 194 | 13 | GO:0005938 |
| GeneOntologyCellularComponent | actin-based cell projection | MYO10 PPP1R9B STRC DMD UTRN CNP STRCP1 TRIOBP NLGN1 LCP1 PKHD1L1 | 6.07e-05 | 278 | 194 | 11 | GO:0098858 |
| GeneOntologyCellularComponent | spectrin | 6.34e-05 | 9 | 194 | 3 | GO:0008091 | |
| GeneOntologyCellularComponent | Z disc | 8.53e-05 | 151 | 194 | 8 | GO:0030018 | |
| GeneOntologyCellularComponent | I band | 1.65e-04 | 166 | 194 | 8 | GO:0031674 | |
| GeneOntologyCellularComponent | sarcomere | 5.50e-04 | 249 | 194 | 9 | GO:0030017 | |
| GeneOntologyCellularComponent | podosome | 5.57e-04 | 41 | 194 | 4 | GO:0002102 | |
| GeneOntologyCellularComponent | pseudopodium | 5.80e-04 | 18 | 194 | 3 | GO:0031143 | |
| GeneOntologyCellularComponent | ruffle | 6.99e-04 | 206 | 194 | 8 | GO:0001726 | |
| GeneOntologyCellularComponent | anchoring junction | DLG5 NCKAP1 CYTH2 SPTAN1 SPTBN2 EVPL ACTN4 ACTN3 ITGA2B RASIP1 PPP1R9B PLEC DMD VCL FERMT3 DPP4 APC TRIOBP LCP1 YWHAB | 7.77e-04 | 976 | 194 | 20 | GO:0070161 |
| GeneOntologyCellularComponent | leading edge membrane | 7.93e-04 | 210 | 194 | 8 | GO:0031256 | |
| GeneOntologyCellularComponent | dystrophin-associated glycoprotein complex | 7.99e-04 | 20 | 194 | 3 | GO:0016010 | |
| GeneOntologyCellularComponent | cell-substrate junction | NCKAP1 ACTN4 ACTN3 ITGA2B PLEC DMD VCL FERMT3 DPP4 TRIOBP LCP1 YWHAB | 9.24e-04 | 443 | 194 | 12 | GO:0030055 |
| GeneOntologyCellularComponent | filopodium membrane | 9.25e-04 | 21 | 194 | 3 | GO:0031527 | |
| GeneOntologyCellularComponent | filopodium | 1.02e-03 | 123 | 194 | 6 | GO:0030175 | |
| GeneOntologyCellularComponent | myofibril | 1.06e-03 | 273 | 194 | 9 | GO:0030016 | |
| GeneOntologyCellularComponent | stereocilium tip | 1.06e-03 | 22 | 194 | 3 | GO:0032426 | |
| GeneOntologyCellularComponent | costamere | 1.06e-03 | 22 | 194 | 3 | GO:0043034 | |
| GeneOntologyCellularComponent | centriole | 1.15e-03 | 172 | 194 | 7 | GO:0005814 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | SPTBN2 EXOC3 ACTN4 CTIF STAT1 RASIP1 CACNA1G PLEC DMD CNP APC ABCC5 CPD LCP1 YWHAB ASL CEP250 AKAP13 MTMR9 | 1.15e-03 | 934 | 194 | 19 | GO:0048471 |
| GeneOntologyCellularComponent | supramolecular fiber | KNTC1 MYH6 NCKAP1 SPTAN1 EVPL ACTN4 ACTN3 KRT80 TEKT2 PLEC DMD DNAH9 CNP VCL ANK1 LRRC10 APC APOE LCP1 MACF1 AKAP13 PCNT | 1.44e-03 | 1179 | 194 | 22 | GO:0099512 |
| GeneOntologyCellularComponent | glycoprotein complex | 1.56e-03 | 25 | 194 | 3 | GO:0090665 | |
| GeneOntologyCellularComponent | supramolecular polymer | KNTC1 MYH6 NCKAP1 SPTAN1 EVPL ACTN4 ACTN3 KRT80 TEKT2 PLEC DMD DNAH9 CNP VCL ANK1 LRRC10 APC APOE LCP1 MACF1 AKAP13 PCNT | 1.57e-03 | 1187 | 194 | 22 | GO:0099081 |
| GeneOntologyCellularComponent | contractile muscle fiber | 1.60e-03 | 290 | 194 | 9 | GO:0043292 | |
| GeneOntologyCellularComponent | mitochondrial outer membrane | 1.91e-03 | 241 | 194 | 8 | GO:0005741 | |
| GeneOntologyCellularComponent | sarcolemma | 2.03e-03 | 190 | 194 | 7 | GO:0042383 | |
| GeneOntologyCellularComponent | manchette | 2.17e-03 | 28 | 194 | 3 | GO:0002177 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 2.20e-03 | 59 | 194 | 4 | GO:0098636 | |
| GeneOntologyCellularComponent | cell projection membrane | NCKAP1 MYO10 PPP1R9B DMD UTRN DPP4 ANK1 APC LCP1 MACF1 MTMR9 | 2.39e-03 | 431 | 194 | 11 | GO:0031253 |
| GeneOntologyCellularComponent | cell leading edge | NCKAP1 MYO10 CYTH2 PTPN13 PPP1R9B DMD DPP4 ANK1 APC LCP1 MACF1 MTMR9 | 2.55e-03 | 500 | 194 | 12 | GO:0031252 |
| GeneOntologyCellularComponent | spectrin-associated cytoskeleton | 2.96e-03 | 9 | 194 | 2 | GO:0014731 | |
| GeneOntologyCellularComponent | ruffle membrane | 3.37e-03 | 108 | 194 | 5 | GO:0032587 | |
| GeneOntologyCellularComponent | synaptic cleft | 3.50e-03 | 33 | 194 | 3 | GO:0043083 | |
| GeneOntologyCellularComponent | stereocilium | 3.89e-03 | 69 | 194 | 4 | GO:0032420 | |
| GeneOntologyCellularComponent | neuromuscular junction | 3.94e-03 | 112 | 194 | 5 | GO:0031594 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | KNTC1 NCKAP1 EVPL ACTN3 KRT80 TEKT2 PLEC DMD DNAH9 CNP VCL APC APOE LCP1 MACF1 AKAP13 PCNT | 4.38e-03 | 899 | 194 | 17 | GO:0099513 |
| GeneOntologyCellularComponent | cell body fiber | 4.46e-03 | 11 | 194 | 2 | GO:0070852 | |
| GeneOntologyCellularComponent | paranodal junction | 4.46e-03 | 11 | 194 | 2 | GO:0033010 | |
| MousePheno | fused cornea and lens | 6.07e-09 | 24 | 158 | 7 | MP:0001307 | |
| MousePheno | cornea opacity | AGAP5 MYO10 SETD6 AGAP11 KRT80 AGAP4 APOE PCSK6 AGAP9 AGAP7P AGAP6 | 1.86e-06 | 159 | 158 | 11 | MP:0001314 |
| MousePheno | persistence of hyaloid vascular system | AGAP5 CACNA2D2 MYO10 SPTAN1 AGAP11 AGAP4 ZFC3H1 TSPAN8 AGAP9 AGAP7P AGAP6 PCNT | 8.59e-06 | 223 | 158 | 12 | MP:0001289 |
| MousePheno | abnormal lens development | 2.78e-05 | 78 | 158 | 7 | MP:0005545 | |
| MousePheno | Purkinje cell degeneration | 3.56e-05 | 81 | 158 | 7 | MP:0000876 | |
| MousePheno | neuron degeneration | CACNA2D2 SPTBN2 STARD9 CACNA1G ANK1 RBP3 APOE ZNF106 CEP250 NEMF CNTNAP4 MACF1 RORA ZFYVE26 CROCC | 3.71e-05 | 391 | 158 | 15 | MP:0003224 |
| MousePheno | absent pinna reflex | 6.54e-05 | 89 | 158 | 7 | MP:0006358 | |
| MousePheno | increased circulating potassium level | 6.81e-05 | 121 | 158 | 8 | MP:0005627 | |
| MousePheno | neurodegeneration | CACNA2D2 SPTBN2 STARD9 CACNA1G CNP ANK1 RBP3 APOE ZNF106 CEP250 NEMF CNTNAP4 MACF1 RORA ZFYVE26 CROCC | 8.03e-05 | 468 | 158 | 16 | MP:0002229 |
| MousePheno | detached sperm flagellum | 8.09e-05 | 21 | 158 | 4 | MP:0008893 | |
| MousePheno | abnormal vitreous body morphology | AGAP5 CACNA2D2 MYO10 SPTAN1 UGGT1 AGAP11 AGAP4 ZFC3H1 ADAMTS12 TSPAN8 AKAP13 AGAP9 AGAP7P AGAP6 PCNT | 1.06e-04 | 429 | 158 | 15 | MP:0002699 |
| MousePheno | abnormal eye development | AGAP5 CACNA2D2 MYO10 SPTAN1 ACTN4 AGAP11 AGAP4 SFN ZFC3H1 PCSK6 TSPAN8 MACF1 AGAP9 AGAP7P AGAP6 PCNT | 1.13e-04 | 482 | 158 | 16 | MP:0001286 |
| MousePheno | abnormal pinna reflex | 1.46e-04 | 101 | 158 | 7 | MP:0001485 | |
| MousePheno | acanthocytosis | 2.19e-04 | 11 | 158 | 3 | MP:0010177 | |
| MousePheno | abnormal skin coloration | 2.24e-04 | 182 | 158 | 9 | MP:0011239 | |
| MousePheno | abnormal cerebral aqueduct morphology | 2.25e-04 | 27 | 158 | 4 | MP:0005537 | |
| MousePheno | abnormal cornea morphology | AGAP5 MYO10 SETD6 AGAP11 STAT1 KRT80 AGAP4 ANKRD35 APOE PCSK6 AGAP9 AGAP7P AGAP6 | 2.65e-04 | 366 | 158 | 13 | MP:0001312 |
| MousePheno | abnormal gait | DLG5 CACNA2D2 SPTBN2 STAT1 STARD9 CACNA1G DMD CNP CACNA1B EFL1 TENT5A ZNF106 NEMF RORA ZFYVE26 LIPI | 2.68e-04 | 520 | 158 | 16 | MP:0001406 |
| MousePheno | abnormal respiratory motile cilium morphology | 2.99e-04 | 29 | 158 | 4 | MP:0011050 | |
| MousePheno | abnormal heart layer morphology | MYH6 ZMYND11 SPTAN1 TRPM2 RASIP1 PLEC DMD VCL DTNA LRRC10 BTAF1 NR2F2 ASL AKAP13 | 3.09e-04 | 422 | 158 | 14 | MP:0010545 |
| MousePheno | abnormal head morphology | DLG5 AGAP5 ZMYND11 SPTAN1 UGGT1 LRRC32 ANO5 ACTN4 AGAP11 AGAP4 MED12 VCL SFN TENT5A APC LAMA5 BTAF1 PCSK6 TTC21B AGAP9 AGAP7P AGAP6 HYDIN MTMR9 XPOT PCNT | 3.30e-04 | 1120 | 158 | 26 | MP:0000432 |
| MousePheno | abnormal foregut morphology | 3.42e-04 | 30 | 158 | 4 | MP:0000474 | |
| MousePheno | nasal inflammation | 3.73e-04 | 13 | 158 | 3 | MP:0001866 | |
| MousePheno | pleuritis | 3.78e-04 | 3 | 158 | 2 | MP:0031053 | |
| Domain | SPEC | SPTAN1 SPTBN2 EVPL ACTN4 ACTN3 SPTBN5 PLEC DMD UTRN EVPLL MACF1 | 8.59e-15 | 32 | 188 | 11 | SM00150 |
| Domain | Spectrin/alpha-actinin | SPTAN1 SPTBN2 EVPL ACTN4 ACTN3 SPTBN5 PLEC DMD UTRN EVPLL MACF1 | 8.59e-15 | 32 | 188 | 11 | IPR018159 |
| Domain | Spectrin_repeat | 1.42e-13 | 29 | 188 | 10 | IPR002017 | |
| Domain | ACTININ_2 | 6.33e-13 | 23 | 188 | 9 | PS00020 | |
| Domain | ACTININ_1 | 6.33e-13 | 23 | 188 | 9 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 6.33e-13 | 23 | 188 | 9 | IPR001589 | |
| Domain | Spectrin | 3.91e-11 | 23 | 188 | 8 | PF00435 | |
| Domain | ArfGap | 3.25e-10 | 29 | 188 | 8 | SM00105 | |
| Domain | ARFGAP | 3.25e-10 | 29 | 188 | 8 | PS50115 | |
| Domain | ArfGap | 3.25e-10 | 29 | 188 | 8 | PF01412 | |
| Domain | ArfGAP | 3.25e-10 | 29 | 188 | 8 | IPR001164 | |
| Domain | CH | 1.72e-08 | 65 | 188 | 9 | SM00033 | |
| Domain | PH | AGAP5 ACAP1 MYO10 CYTH2 SPTBN2 AGAP11 SPTBN5 AGAP4 FERMT3 AGAP3 ARHGAP23 TRIOBP AKAP13 AGAP9 AGAP7P AGAP6 | 2.30e-08 | 278 | 188 | 16 | SM00233 |
| Domain | PH_DOMAIN | AGAP5 ACAP1 MYO10 CYTH2 SPTBN2 AGAP11 SPTBN5 AGAP4 FERMT3 AGAP3 ARHGAP23 TRIOBP AKAP13 AGAP9 AGAP7P AGAP6 | 2.42e-08 | 279 | 188 | 16 | PS50003 |
| Domain | PH_domain | AGAP5 ACAP1 MYO10 CYTH2 SPTBN2 AGAP11 SPTBN5 AGAP4 FERMT3 AGAP3 ARHGAP23 TRIOBP AKAP13 AGAP9 AGAP7P AGAP6 | 2.55e-08 | 280 | 188 | 16 | IPR001849 |
| Domain | CH | 3.36e-08 | 70 | 188 | 9 | PF00307 | |
| Domain | - | 3.81e-08 | 71 | 188 | 9 | 1.10.418.10 | |
| Domain | CH | 4.88e-08 | 73 | 188 | 9 | PS50021 | |
| Domain | CH-domain | 6.21e-08 | 75 | 188 | 9 | IPR001715 | |
| Domain | Ankyrin_rpt-contain_dom | AGAP5 ACAP1 AGAP11 ANKRD12 AGAP4 AGAP3 ANKRD35 ANK1 ANKDD1A KANK4 AKAP13 AGAP9 AGAP7P AGAP6 | 3.05e-07 | 254 | 188 | 14 | IPR020683 |
| Domain | PH_dom-like | AGAP5 ACAP1 MYO10 CYTH2 SPTBN2 AGAP11 SPTBN5 PTPN13 AGAP4 FERMT3 AGAP3 ARHGAP23 TRIOBP AKAP13 AGAP9 AGAP7P AGAP6 MTMR9 | 3.25e-07 | 426 | 188 | 18 | IPR011993 |
| Domain | - | AGAP5 ACAP1 MYO10 CYTH2 SPTBN2 AGAP11 SPTBN5 PTPN13 AGAP4 FERMT3 AGAP3 ARHGAP23 TRIOBP AKAP13 AGAP9 AGAP6 MTMR9 | 4.71e-07 | 391 | 188 | 17 | 2.30.29.30 |
| Domain | - | AGAP5 ACAP1 AGAP11 ANKRD12 AGAP4 AGAP3 ANKRD35 ANK1 ANKDD1A KANK4 AKAP13 AGAP9 AGAP6 | 1.43e-06 | 248 | 188 | 13 | 1.25.40.20 |
| Domain | ANK_REP_REGION | AGAP5 ACAP1 AGAP11 ANKRD12 AGAP4 AGAP3 ANKRD35 ANK1 ANKDD1A KANK4 AGAP9 AGAP7P AGAP6 | 1.87e-06 | 254 | 188 | 13 | PS50297 |
| Domain | Ankyrin_rpt | TRPM4 AGAP5 ACAP1 AGAP11 ANKRD12 AGAP4 AGAP3 ANKRD35 ANK1 ANKDD1A KANK4 AGAP7P AGAP6 | 2.64e-06 | 262 | 188 | 13 | IPR002110 |
| Domain | PH | ACAP1 MYO10 CYTH2 SPTBN2 AGAP11 SPTBN5 AGAP4 FERMT3 AGAP3 TRIOBP AKAP13 AGAP7P | 3.69e-06 | 229 | 188 | 12 | PF00169 |
| Domain | ANK | AGAP5 ACAP1 AGAP11 ANKRD12 AGAP4 AGAP3 ANKRD35 ANK1 ANKDD1A KANK4 AGAP7P AGAP6 | 9.40e-06 | 251 | 188 | 12 | SM00248 |
| Domain | ANK_REPEAT | AGAP5 ACAP1 AGAP11 ANKRD12 AGAP4 AGAP3 ANKRD35 ANK1 ANKDD1A KANK4 AGAP7P AGAP6 | 1.02e-05 | 253 | 188 | 12 | PS50088 |
| Domain | - | 1.96e-05 | 6 | 188 | 3 | 3.90.1290.10 | |
| Domain | EFhand_Ca_insen | 1.96e-05 | 6 | 188 | 3 | PF08726 | |
| Domain | - | 1.96e-05 | 6 | 188 | 3 | 2.140.10.30 | |
| Domain | DPPIV_N | 1.96e-05 | 6 | 188 | 3 | PF00930 | |
| Domain | EF-hand_Ca_insen | 1.96e-05 | 6 | 188 | 3 | IPR014837 | |
| Domain | EF-hand_dom_typ1 | 1.96e-05 | 6 | 188 | 3 | IPR015153 | |
| Domain | EF-hand_dom_typ2 | 1.96e-05 | 6 | 188 | 3 | IPR015154 | |
| Domain | EF-hand_2 | 1.96e-05 | 6 | 188 | 3 | PF09068 | |
| Domain | EF-hand_3 | 1.96e-05 | 6 | 188 | 3 | PF09069 | |
| Domain | Peptidase_S9B_N | 1.96e-05 | 6 | 188 | 3 | IPR002469 | |
| Domain | Plectin | 3.41e-05 | 7 | 188 | 3 | PF00681 | |
| Domain | Plectin_repeat | 3.41e-05 | 7 | 188 | 3 | IPR001101 | |
| Domain | PLEC | 3.41e-05 | 7 | 188 | 3 | SM00250 | |
| Domain | Ank_2 | AGAP5 ACAP1 AGAP11 ANKRD12 AGAP4 AGAP3 ANKRD35 ANK1 ANKDD1A AGAP6 | 6.66e-05 | 215 | 188 | 10 | PF12796 |
| Domain | CCDC74 | 1.01e-04 | 2 | 188 | 2 | IPR033226 | |
| Domain | CCDC74_C | 1.01e-04 | 2 | 188 | 2 | IPR029422 | |
| Domain | Dystrophin | 1.01e-04 | 2 | 188 | 2 | IPR016344 | |
| Domain | CCDC74_C | 1.01e-04 | 2 | 188 | 2 | PF14917 | |
| Domain | Envoplakin | 1.01e-04 | 2 | 188 | 2 | IPR030460 | |
| Domain | Ank | ACAP1 AGAP11 ANKRD12 AGAP4 AGAP3 ANKRD35 ANK1 ANKDD1A KANK4 AGAP7P | 1.08e-04 | 228 | 188 | 10 | PF00023 |
| Domain | Peptidase_S9 | 1.56e-04 | 11 | 188 | 3 | PF00326 | |
| Domain | Peptidase_S9 | 1.56e-04 | 11 | 188 | 3 | IPR001375 | |
| Domain | EF-hand-dom_pair | SPTAN1 ACTN4 ACTN3 STAT1 STAT3 DMD UTRN CACNA1B DTNA LCP1 MACF1 | 1.63e-04 | 287 | 188 | 11 | IPR011992 |
| Domain | Rubis-subs-bind | 3.00e-04 | 3 | 188 | 2 | PF09273 | |
| Domain | Rubisco_LSMT_subst-bd | 3.00e-04 | 3 | 188 | 2 | IPR015353 | |
| Domain | - | 3.23e-04 | 261 | 188 | 10 | 1.10.238.10 | |
| Domain | Bestrophin | 5.97e-04 | 4 | 188 | 2 | PF01062 | |
| Domain | Bestrophin/UPF0187 | 5.97e-04 | 4 | 188 | 2 | IPR021134 | |
| Domain | DC_STAMP-like | 5.97e-04 | 4 | 188 | 2 | IPR012858 | |
| Domain | Bestrophin | 5.97e-04 | 4 | 188 | 2 | IPR000615 | |
| Domain | DC_STAMP | 5.97e-04 | 4 | 188 | 2 | PF07782 | |
| Domain | ZF_ZZ_2 | 7.33e-04 | 18 | 188 | 3 | PS50135 | |
| Domain | ZF_ZZ_1 | 7.33e-04 | 18 | 188 | 3 | PS01357 | |
| Domain | ZZ | 7.33e-04 | 18 | 188 | 3 | PF00569 | |
| Domain | Znf_ZZ | 8.64e-04 | 19 | 188 | 3 | IPR000433 | |
| Domain | ZnF_ZZ | 8.64e-04 | 19 | 188 | 3 | SM00291 | |
| Domain | Nlgn | 9.88e-04 | 5 | 188 | 2 | IPR000460 | |
| Domain | - | 1.30e-03 | 119 | 188 | 6 | 3.40.50.1820 | |
| Domain | AB_hydrolase | 1.30e-03 | 119 | 188 | 6 | IPR029058 | |
| Domain | Xpo1 | 1.47e-03 | 6 | 188 | 2 | PF08389 | |
| Domain | Exportin-1/Importin-b-like | 1.47e-03 | 6 | 188 | 2 | IPR013598 | |
| Domain | 14_3_3 | 2.05e-03 | 7 | 188 | 2 | SM00101 | |
| Domain | STAT_TF_DNA-bd_sub | 2.05e-03 | 7 | 188 | 2 | IPR012345 | |
| Domain | STAT | 2.05e-03 | 7 | 188 | 2 | IPR001217 | |
| Domain | 1433_1 | 2.05e-03 | 7 | 188 | 2 | PS00796 | |
| Domain | 1433_2 | 2.05e-03 | 7 | 188 | 2 | PS00797 | |
| Domain | 14-3-3_domain | 2.05e-03 | 7 | 188 | 2 | IPR023410 | |
| Domain | 14-3-3_CS | 2.05e-03 | 7 | 188 | 2 | IPR023409 | |
| Domain | 14-3-3 | 2.05e-03 | 7 | 188 | 2 | PF00244 | |
| Domain | STAT_int | 2.05e-03 | 7 | 188 | 2 | SM00964 | |
| Domain | STAT_TF_DNA-bd | 2.05e-03 | 7 | 188 | 2 | IPR013801 | |
| Domain | STAT_bind | 2.05e-03 | 7 | 188 | 2 | PF02864 | |
| Domain | STAT_int | 2.05e-03 | 7 | 188 | 2 | PF02865 | |
| Domain | - | 2.05e-03 | 7 | 188 | 2 | 1.10.532.10 | |
| Domain | STAT_alpha | 2.05e-03 | 7 | 188 | 2 | PF01017 | |
| Domain | - | 2.05e-03 | 7 | 188 | 2 | 1.20.1050.20 | |
| Domain | STAT_TF_prot_interaction | 2.05e-03 | 7 | 188 | 2 | IPR013799 | |
| Domain | STAT_TF_coiled-coil | 2.05e-03 | 7 | 188 | 2 | IPR015988 | |
| Domain | - | 2.05e-03 | 7 | 188 | 2 | 2.60.40.630 | |
| Domain | P-loop_NTPase | DLG5 MYH6 MYO10 NWD2 NOD1 STARD9 DDX43 DNAH9 CNP AGAP3 EFL1 NWD1 ABCC5 BTAF1 AAGAB CHST4 AGAP9 HYDIN | 2.33e-03 | 848 | 188 | 18 | IPR027417 |
| Domain | 14-3-3 | 2.71e-03 | 8 | 188 | 2 | IPR000308 | |
| Domain | STAT_TF_alpha | 2.71e-03 | 8 | 188 | 2 | IPR013800 | |
| Domain | - | 2.71e-03 | 8 | 188 | 2 | 2.60.40.360 | |
| Domain | PH_dom-spectrin-type | 3.46e-03 | 9 | 188 | 2 | IPR001605 | |
| Domain | PapD-like | 3.46e-03 | 9 | 188 | 2 | IPR008962 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 1.43e-06 | 10 | 131 | 4 | MM15112 | |
| Pubmed | AGAP5 NCKAP1 ACTN4 AGAP11 ARMCX1 PTPN13 NWD2 STARD9 PPP1R9B NLGN2 AGAP4 VCL AGAP3 ARHGAP23 DTNA APC BTBD17 YWHAB CEP250 MACF1 AGAP9 AGAP7P AGAP6 | 5.50e-16 | 430 | 196 | 23 | 32581705 | |
| Pubmed | GGAPs, a new family of bifunctional GTP-binding and GTPase-activating proteins. | 5.78e-15 | 9 | 196 | 7 | 12640130 | |
| Pubmed | AGAP1, a novel binding partner of nitric oxide-sensitive guanylyl cyclase. | 5.25e-14 | 11 | 196 | 7 | 15381706 | |
| Pubmed | AGAP1/AP-3-dependent endocytic recycling of M5 muscarinic receptors promotes dopamine release. | 6.11e-12 | 10 | 196 | 6 | 20664521 | |
| Pubmed | 4.93e-11 | 13 | 196 | 6 | 27713690 | ||
| Pubmed | 8.58e-11 | 14 | 196 | 6 | 22453919 | ||
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | AGAP5 NCKAP1 SPTAN1 SPTBN2 ACTN4 AGAP11 PPP1R9B AGAP4 DMXL2 NLGN1 MACF1 AGAP9 AGAP7P AGAP6 | 8.67e-10 | 281 | 196 | 14 | 28706196 |
| Pubmed | USP11 SPTAN1 SPTBN2 ACTN4 GTF3C4 STAT1 STAT3 PTPN13 SARS2 PLEC UTRN AGAP3 CA11 DMXL2 KDM5A APC TRIOBP ABCC5 ZFC3H1 APOE YWHAB PCSK6 NEMF MACF1 LRPAP1 XPOT PCNT | 4.43e-09 | 1285 | 196 | 27 | 35914814 | |
| Pubmed | CYTH2 SPTAN1 SPTBN2 EVPL ACTN4 STAT1 MCM3AP PLEC DMD APC YWHAB ZNF106 CEP250 MACF1 LRPAP1 AKAP13 | 2.00e-08 | 486 | 196 | 16 | 20936779 | |
| Pubmed | 2.51e-08 | 118 | 196 | 9 | 30979931 | ||
| Pubmed | 1.76e-07 | 3 | 196 | 3 | 9499411 | ||
| Pubmed | Role for alpha-dystrobrevin in the pathogenesis of dystrophin-dependent muscular dystrophies. | 1.76e-07 | 3 | 196 | 3 | 10559919 | |
| Pubmed | 1.76e-07 | 3 | 196 | 3 | 10719885 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | TBC1D19 TRPM4 CACNA2D2 TRPM2 CTIF PTPN13 SLC8B1 PPP1R9B NLGN2 ANKRD12 UTRN AGAP3 DPP6 BEST1 DTNA TRIOBP CPD BTAF1 DENND1A NEMF TTC21B MACF1 RCOR3 AKAP13 CROCC PCNT | 3.35e-07 | 1489 | 196 | 26 | 28611215 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TRPM4 MYO10 KIAA2013 SLC8B1 SARS2 MCM3AP ULK4 NLGN2 WDR90 PLEC MED12 WDR24 AGAP3 NLRX1 LAMA5 BTAF1 DENND1A NR2F2 AKAP13 ZFYVE26 TNPO3 PCNT | 3.35e-07 | 1105 | 196 | 22 | 35748872 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DLG5 NCKAP1 SPTAN1 STAT3 PTPN13 STARD9 PLEC UTRN SFN AGAP3 KDM5A APC YWHAB DENND1A ZNF106 MACF1 AKAP13 AKAP1 TNPO3 | 4.88e-07 | 861 | 196 | 19 | 36931259 |
| Pubmed | MYH6 NCKAP1 CYTH2 SPTAN1 SPTBN2 ACTN4 ACTN3 NWD2 PPP1R9B PLEC DMD UTRN CNP VCL AGAP3 DPP6 DMXL2 ARHGAP23 RBP3 APC APOE YWHAB PPP1R18 MACF1 CROCC | 5.71e-07 | 1431 | 196 | 25 | 37142655 | |
| Pubmed | 7.02e-07 | 4 | 196 | 3 | 9701558 | ||
| Pubmed | RIM-BP3 is a manchette-associated protein essential for spermiogenesis. | 7.02e-07 | 4 | 196 | 3 | 19091768 | |
| Pubmed | Syntrophin binds to an alternatively spliced exon of dystrophin. | 7.02e-07 | 4 | 196 | 3 | 7844150 | |
| Pubmed | 7.02e-07 | 4 | 196 | 3 | 21204268 | ||
| Pubmed | 7.02e-07 | 4 | 196 | 3 | 17389230 | ||
| Pubmed | GTF3C4 RCOR2 PTPN13 NR0B1 PLEC UTRN MED12 HOMEZ KDM5A APC RCOR3 AKAP1 PCNT | 8.40e-07 | 418 | 196 | 13 | 34709266 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | DLG5 SPTAN1 SPTBN2 EXOC3 EVPL SIRPA STAT1 PLEC UTRN VCL SFN ARHGAP23 YWHAB PPP1R18 MACF1 | 8.69e-07 | 565 | 196 | 15 | 25468996 |
| Pubmed | KNTC1 SPTBN2 CTIF KIAA2013 LRIG2 NLGN2 MED12 DMXL2 ARHGAP23 ZFC3H1 TLR1 TTC21B CNTNAP4 MACF1 | 9.26e-07 | 493 | 196 | 14 | 15368895 | |
| Pubmed | TBC1D19 SPTAN1 EVPL PLEC UTRN SFN APC TRIOBP BTAF1 PPP1R18 MACF1 PCNT | 1.09e-06 | 360 | 196 | 12 | 33111431 | |
| Pubmed | Suppressors of cytokine signaling modulate JAK/STAT-mediated cell responses during atherosclerosis. | 1.75e-06 | 5 | 196 | 3 | 19164812 | |
| Pubmed | Role of dystrophins and utrophins in platelet adhesion process. | 1.75e-06 | 5 | 196 | 3 | 16803572 | |
| Pubmed | Structure and evolution of RIM-BP genes: identification of a novel family member. | 1.75e-06 | 5 | 196 | 3 | 17855024 | |
| Pubmed | DLG5 AGAP5 AGAP11 AGO4 CACNA1G WDR90 AGAP4 HOMEZ NEMP1 TRIOBP LAMA5 AGAP9 AGAP7P AGAP6 | 2.11e-06 | 529 | 196 | 14 | 14621295 | |
| Pubmed | Organization of focal adhesion plaques is disrupted by action of the HIV-1 protease. | 2.81e-06 | 18 | 196 | 4 | 12119179 | |
| Pubmed | Different dystrophin-like complexes are expressed in neurons and glia. | 3.48e-06 | 6 | 196 | 3 | 10545507 | |
| Pubmed | 3.48e-06 | 6 | 196 | 3 | 8576247 | ||
| Pubmed | 3.48e-06 | 6 | 196 | 3 | 10767429 | ||
| Pubmed | AGAP5 BRINP1 SIRPA AGAP11 AGAP4 AGAP3 DPP6 DPP10 NLGN1 AGAP9 AGAP7P AGAP6 | 3.68e-06 | 405 | 196 | 12 | 38187761 | |
| Pubmed | SPTAN1 ACTN4 KRT80 PLEC DMD VCL SFN TRIOBP LAMA5 LCP1 YWHAB PPP1R18 MACF1 | 4.58e-06 | 488 | 196 | 13 | 31324722 | |
| Pubmed | CTU2 NCKAP1 SPTAN1 UGGT1 ACTN4 STAT1 STAT3 CNP APC LAMA5 CPD YWHAB DERA ZNF106 NEMF MACF1 LRPAP1 AKAP13 CROCC AKAP1 TNPO3 XPOT | 4.59e-06 | 1297 | 196 | 22 | 33545068 | |
| Pubmed | NCKAP1 USP11 SPTAN1 UGGT1 SPTBN2 ACTN4 MCM3AP PLEC UTRN MED12 VCL LCP1 MACF1 XPOT PCNT | 5.08e-06 | 653 | 196 | 15 | 22586326 | |
| Pubmed | NCKAP1 SPTBN2 SPTBN5 ATRIP PLEC CNP CACNA1B LAMA5 YWHAB TRUB2 NEMF MACF1 TOP2A | 5.46e-06 | 496 | 196 | 13 | 31343991 | |
| Pubmed | USP11 SETD6 ACTN4 ACTN3 PLEC UTRN VCL DMXL2 KDM5A DTNA MACF1 RCOR3 AKAP1 | 5.58e-06 | 497 | 196 | 13 | 23414517 | |
| Pubmed | Cytoplasmic gamma-actin expression in diverse animal models of muscular dystrophy. | 6.07e-06 | 7 | 196 | 3 | 17475492 | |
| Pubmed | ZMYND11 SVEP1 MCM3AP PPP1R9B PLEC UTRN VCL TENT5A LAMA5 NR2F2 ZNF106 CEP250 MACF1 TNPO3 | 7.48e-06 | 591 | 196 | 14 | 15231748 | |
| Pubmed | KNTC1 MYH6 SPTAN1 UGGT1 SPTBN2 ACTN4 ACTN3 KIAA2013 STARD9 PPP1R9B PLEC DMD SFN KDM5A DTNA ABCC5 ZFC3H1 LCP1 YWHAB ADAMTS12 MACF1 TOP2A PCNT | 7.50e-06 | 1442 | 196 | 23 | 35575683 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | DLG5 AGPAT5 NCKAP1 SPTBN2 ACTN4 CTIF STAT3 PLEC VCL APC CPD LCP1 RIMBP3 CEP250 TOP2A MTMR9 PCNT | 7.69e-06 | 853 | 196 | 17 | 28718761 |
| Pubmed | Expanding the Interactome of TES by Exploiting TES Modules with Different Subcellular Localizations. | 8.23e-06 | 235 | 196 | 9 | 28378594 | |
| Pubmed | MOSPD2 SPTAN1 UGGT1 SPTBN2 EXOC3 ACTN4 PTPN13 PPP1R9B DMD UTRN EFL1 DTNA TRIOBP CPD YWHAB PPP1R18 MTMR9 XPOT PCNT | 8.58e-06 | 1049 | 196 | 19 | 27880917 | |
| Pubmed | NCKAP1 CYTH2 SPTAN1 SPTBN2 SIRPA RCOR2 LRIG2 PPP1R9B NLGN2 CNP FERMT3 DMXL2 KDM5A APC TRIOBP YWHAB MACF1 PCNT | 9.82e-06 | 963 | 196 | 18 | 28671696 | |
| Pubmed | NDP52 interacts with mitochondrial RNA poly(A) polymerase to promote mitophagy. | 1.13e-05 | 25 | 196 | 4 | 30309841 | |
| Pubmed | 1.19e-05 | 187 | 196 | 8 | 26460568 | ||
| Pubmed | MYO10 CYTH2 SPTAN1 ACTN4 STAT3 DMD UTRN VCL SFN AGAP3 YWHAB MACF1 TOP2A | 1.30e-05 | 538 | 196 | 13 | 28524877 | |
| Pubmed | TRPM4 DLG5 NCKAP1 STAT1 KIAA2013 PTPN13 CCNL1 TADA3 UTRN FKBP3 MED12 CNP AGAP3 KDM5A APC TRIOBP LAMA5 ZFC3H1 DENND1A PPP1R18 MACF1 CROCC AKAP1 | 1.36e-05 | 1497 | 196 | 23 | 31527615 | |
| Pubmed | 1.39e-05 | 251 | 196 | 9 | 27507650 | ||
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | MYH6 SPTAN1 UGGT1 ACTN4 ACTN3 KRT80 PLEC VCL SFN LAMA5 YWHAB TNPO3 TOP2A XPOT | 2.05e-05 | 647 | 196 | 14 | 26618866 |
| Pubmed | Cell organization, growth, and neural and cardiac development require αII-spectrin. | 2.05e-05 | 10 | 196 | 3 | 22159418 | |
| Pubmed | MYO10 SPTAN1 ACTN4 GTF3C4 PLEC ANK1 TENT5A NR2F2 MACF1 TOP2A | 2.09e-05 | 332 | 196 | 10 | 37433992 | |
| Pubmed | 2.12e-05 | 147 | 196 | 7 | 16959763 | ||
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | AGAP5 MYO10 USP11 ACTN4 AGAP11 RCOR2 AGAP4 FKBP3 VWA5B1 HOMEZ DMXL2 SETD4 APOE TRUB2 ZNF106 CEP250 CD300LG AGAP9 AGAP7P AGAP6 | 2.68e-05 | 1242 | 196 | 20 | 30973865 |
| Pubmed | 2.81e-05 | 11 | 196 | 3 | 10995443 | ||
| Pubmed | 2.81e-05 | 11 | 196 | 3 | 16857187 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | NCKAP1 SPTBN2 EXOC3 GTF3C4 MED12 NWD1 ANK1 APOE LCP1 ZNF106 HYDIN XPOT | 2.82e-05 | 497 | 196 | 12 | 36774506 |
| Pubmed | CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI. | 2.85e-05 | 104 | 196 | 6 | 31240132 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | NCKAP1 USP11 SPTAN1 EXOC3 ACTN4 ARMCX1 GTF3C4 STAT1 MCM3AP DDX43 PLEC UTRN MED12 CNP VCL ARHGAP23 YWHAB MACF1 AKAP13 TOP2A XPOT | 2.86e-05 | 1353 | 196 | 21 | 29467282 |
| Pubmed | 3.00e-05 | 105 | 196 | 6 | 9628581 | ||
| Pubmed | 3.11e-05 | 32 | 196 | 4 | 23704327 | ||
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 10525423 | ||
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 26264041 | ||
| Pubmed | In Vivo Genome Editing Restores Dystrophin Expression and Cardiac Function in Dystrophic Mice. | 3.16e-05 | 2 | 196 | 2 | 28790199 | |
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 32357246 | ||
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 12832402 | ||
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 11579100 | ||
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 26974331 | ||
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 14978477 | ||
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 7987307 | ||
| Pubmed | Comparative analysis of the human dystrophin and utrophin gene structures. | 3.16e-05 | 2 | 196 | 2 | 11861579 | |
| Pubmed | Distinct mechanical properties in homologous spectrin-like repeats of utrophin. | 3.16e-05 | 2 | 196 | 2 | 30914715 | |
| Pubmed | Haploinsufficiency of utrophin gene worsens skeletal muscle inflammation and fibrosis in mdx mice. | 3.16e-05 | 2 | 196 | 2 | 17889902 | |
| Pubmed | Characterization of the Ang/Tie2 Signaling Pathway in the Diaphragm Muscle of DMD Mice. | 3.16e-05 | 2 | 196 | 2 | 37626761 | |
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 37203562 | ||
| Pubmed | Targeting signal transducer and activator of transcription signaling pathway in leukemias. | 3.16e-05 | 2 | 196 | 2 | 19667270 | |
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 26516677 | ||
| Pubmed | Assessment of cardiac function in three mouse dystrophinopathies by magnetic resonance imaging. | 3.16e-05 | 2 | 196 | 2 | 22209498 | |
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 10694796 | ||
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 26939627 | ||
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 24337461 | ||
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 11297940 | ||
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 21372127 | ||
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 22388933 | ||
| Pubmed | Utrophin Compensates dystrophin Loss during Mouse Spermatogenesis. | 3.16e-05 | 2 | 196 | 2 | 28785010 | |
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 16307000 | ||
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 33969570 | ||
| Pubmed | TRPM2 Promotes Atherosclerotic Progression in a Mouse Model of Atherosclerosis. | 3.16e-05 | 2 | 196 | 2 | 35563730 | |
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 21949353 | ||
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 23097179 | ||
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 15501597 | ||
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 32619495 | ||
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 18973234 | ||
| Pubmed | 3.16e-05 | 2 | 196 | 2 | 27881412 | ||
| Pubmed | Utrophin influences mitochondrial pathology and oxidative stress in dystrophic muscle. | 3.16e-05 | 2 | 196 | 2 | 29065908 | |
| Pubmed | Stabilization of the cardiac sarcolemma by sarcospan rescues DMD-associated cardiomyopathy. | 3.16e-05 | 2 | 196 | 2 | 31039133 | |
| Pubmed | Dystrophin and dystrophin-related protein in the brains of normal and mdx mice. | 3.16e-05 | 2 | 196 | 2 | 8159184 | |
| Interaction | SLC6A4 interactions | NCKAP1 ACTN4 ARMCX1 PTPN13 NWD2 STARD9 PPP1R9B NLGN2 VCL AGAP3 ARHGAP23 DTNA APC BTBD17 YWHAB CEP250 MACF1 | 9.04e-07 | 437 | 190 | 17 | int:SLC6A4 |
| Interaction | ACTA1 interactions | NCKAP1 MYO10 SPTAN1 SPTBN2 ACTN4 PPP1R9B PLEC DMD UTRN VCL SFN DTNA MACF1 XPOT | 1.21e-05 | 371 | 190 | 14 | int:ACTA1 |
| GeneFamily | X-linked mental retardation|Rho GTPase activating proteins|BAR-PH domain containing | 1.92e-11 | 17 | 134 | 7 | 1291 | |
| GeneFamily | ArfGAPs | 8.76e-11 | 33 | 134 | 8 | 395 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | AGAP5 ACAP1 MYO10 CYTH2 SPTBN2 AGAP4 FERMT3 AGAP3 ARHGAP23 TRIOBP AKAP13 AGAP9 AGAP7P AGAP6 | 4.11e-10 | 206 | 134 | 14 | 682 |
| GeneFamily | Ankyrin repeat domain containing | AGAP5 ACAP1 AGAP11 ANKRD12 AGAP4 AGAP3 ANKRD35 ANK1 ANKDD1A KANK4 AGAP9 AGAP7P AGAP6 | 3.03e-08 | 242 | 134 | 13 | 403 |
| GeneFamily | EF-hand domain containing|Plakins | 1.97e-07 | 8 | 134 | 4 | 939 | |
| GeneFamily | EF-hand domain containing|Spectrins | 1.36e-05 | 7 | 134 | 3 | 1113 | |
| GeneFamily | CD molecules|DASH family | 1.36e-05 | 7 | 134 | 3 | 1205 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 2.99e-04 | 18 | 134 | 3 | 91 | |
| GeneFamily | Actinins | 3.24e-04 | 4 | 134 | 2 | 1112 | |
| GeneFamily | Bestrophins | 3.24e-04 | 4 | 134 | 2 | 866 | |
| GeneFamily | Calcium voltage-gated channel subunits | 9.14e-04 | 26 | 134 | 3 | 253 | |
| GeneFamily | 14-3-3 phospho-serine/phospho-threonine binding proteins | 1.12e-03 | 7 | 134 | 2 | 1053 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 2.31e-03 | 181 | 134 | 6 | 694 | |
| GeneFamily | Potassium voltage-gated channel regulatory subunits|DASH family | 5.37e-03 | 15 | 134 | 2 | 858 | |
| GeneFamily | Nuclear hormone receptors | 5.72e-03 | 49 | 134 | 3 | 71 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 6.05e-03 | 50 | 134 | 3 | 1293 | |
| Coexpression | THEODOROU_MAMMARY_TUMORIGENESIS | 9.31e-09 | 37 | 194 | 7 | MM1121 | |
| Coexpression | KARLSSON_TGFB1_TARGETS_DN | AGAP5 AGAP11 STAT3 PTPN13 NOD1 NLGN2 AGAP4 LAMA5 PKHD1L1 AGAP9 AGAP7P AGAP6 | 5.67e-08 | 209 | 194 | 12 | MM1058 |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | KNTC1 RAPGEF5 CYTH2 SPTAN1 ACTN4 VCL APC CEP250 AKAP13 TOP2A PCNT | 3.01e-07 | 199 | 194 | 11 | M5893 |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN | 8.50e-07 | 44 | 194 | 6 | MM485 | |
| Coexpression | NIKOLSKY_BREAST_CANCER_12Q13_Q21_AMPLICON | 2.26e-05 | 46 | 194 | 5 | M13709 | |
| Coexpression | CHYLA_CBFA2T3_TARGETS_DN | AGAP5 AGAP11 AGAP4 CCDC74B ANK1 CCDC74A TSPAN8 AGAP9 AGAP7P AGAP6 | 2.85e-05 | 263 | 194 | 10 | MM1295 |
| Coexpression | TARTE_PLASMA_CELL_VS_PLASMABLAST_UP | RAPGEF5 SIRPA ITGA2B ITGAD ADAM8 DMD CACNA1B DPP6 RBP3 APOE PCSK6 TLR1 | 4.48e-05 | 398 | 194 | 12 | M4872 |
| ToppCell | droplet-Liver-nan-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | NCKAP1 LRRC32 ARMCX1 RASIP1 BMP2 MRC1 DPP4 ARHGAP23 NR2F2 CD300LG RCOR3 | 5.09e-10 | 183 | 193 | 11 | 709a486154b3157427deb3b8886b63ac39ea42dd |
| ToppCell | droplet-Liver-nan-3m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | NCKAP1 LRRC32 ARMCX1 RASIP1 BMP2 MRC1 DPP4 ARHGAP23 NR2F2 CD300LG RCOR3 | 5.09e-10 | 183 | 193 | 11 | dc06f19f6f80f4c7f13f1f990c1fe0f91ba64ea7 |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYO10 LRRC32 ARMCX1 RASIP1 BMP2 MRC1 DPP4 CYP26B1 ARHGAP23 NR2F2 CD300LG | 1.11e-09 | 197 | 193 | 11 | d584d0334ea97e3fa8c4cd869f5eeea2c7a1ed04 |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RAPGEF5 MYO10 LRRC32 RASIP1 BMP2 MRC1 DPP4 CYP26B1 NR2F2 MACF1 CD300LG | 1.11e-09 | 197 | 193 | 11 | a6aaa6faea348291023f0bc4b0f83fbc67d91da6 |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYO10 LRRC32 ARMCX1 RASIP1 BMP2 MRC1 DPP4 CYP26B1 ARHGAP23 NR2F2 CD300LG | 1.11e-09 | 197 | 193 | 11 | 412091994196a06c2779b4c2cfed84be889a5f8d |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RAPGEF5 MYO10 LRRC32 RASIP1 BMP2 MRC1 DPP4 CYP26B1 NR2F2 MACF1 CD300LG | 1.11e-09 | 197 | 193 | 11 | deefb492b5f0e6014144bd465c4a6ae4206e8739 |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RAPGEF5 MYO10 LRRC32 RASIP1 BMP2 MRC1 DPP4 CYP26B1 NR2F2 MACF1 CD300LG | 1.17e-09 | 198 | 193 | 11 | f0f1816a0ed3ae8207442602f5cbe4de0382e4b3 |
| ToppCell | droplet-Liver-nan-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | NCKAP1 RAPGEF5 LRRC32 ARMCX1 RASIP1 BMP2 DPP4 CPD NR2F2 CD300LG | 7.14e-09 | 181 | 193 | 10 | a53f05c4c47465ee62e353716456bd09ab464b23 |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 8.00e-09 | 135 | 193 | 9 | ae2d3a42e567b5bade304c0caa497eb725be3565 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | NCKAP1 ARMCX1 RASIP1 BMP2 TEKT2 PTPN13 CYP26B1 LAMA5 NR2F2 CD300LG | 8.81e-09 | 185 | 193 | 10 | bdd2e6cb20294b39a9d856004bf57ba69cf877e2 |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-08 | 155 | 193 | 9 | 8fdda4e3657ac56188ae88ed3caf145f4d9d1567 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 6.24e-08 | 171 | 193 | 9 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | Ciliated_cells-A-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 9.68e-08 | 180 | 193 | 9 | d9be152773fe9f2160edad9246fa03c03afeafd6 | |
| ToppCell | LAM-Epithelial-AirwayEpi|LAM / Condition, Lineage and Cell class | 1.68e-07 | 192 | 193 | 9 | 7404fc65be3b7bd09447725b43fa31819004dfee | |
| ToppCell | LAM-Epithelial-AirwayEpi|Epithelial / Condition, Lineage and Cell class | 1.75e-07 | 193 | 193 | 9 | f2672d2c495ee12c3b7d132452bde581fa5a7856 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-07 | 193 | 193 | 9 | 2483bb7f398e4fa0ef09c8bd584ed25703853f03 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | LRRC32 ARMCX1 RASIP1 BMP2 MRC1 CYP26B1 ARHGAP23 NR2F2 CD300LG | 1.91e-07 | 195 | 193 | 9 | ea1b00805391dca8be0883b635768b296369919a |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | LRRC32 ARMCX1 RASIP1 BMP2 MRC1 CYP26B1 ARHGAP23 NR2F2 CD300LG | 1.91e-07 | 195 | 193 | 9 | 126f46dd15dddcf5701144718bb8ba1ce84b2d1d |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | LRRC32 ARMCX1 RASIP1 BMP2 MRC1 CYP26B1 ARHGAP23 NR2F2 CD300LG | 1.91e-07 | 195 | 193 | 9 | f55ab1018a6cde7d517b53e6ce44c3f7bde485c4 |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.00e-07 | 196 | 193 | 9 | 81900dcc9451ff6606ec940c16b559d73247590e | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.09e-07 | 197 | 193 | 9 | 5c4cee914baf7cb43e9cb99cc9e3ae823856dc15 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_other|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.37e-07 | 200 | 193 | 9 | 78d75d381cb2b9a4c9eb7c32a07b014eaee39195 | |
| ToppCell | Ciliated_cells-B-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 1.71e-06 | 188 | 193 | 8 | 606907c865bd2f11bb6474932716550f7723d858 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.78e-06 | 189 | 193 | 8 | dc440015949a768188c67661b6be63b1ead1a0f0 | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_mature-endo_bronchial_(8)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.78e-06 | 189 | 193 | 8 | 4bc3826e0515b3cf2e2ef72a7b2cf9c32ade1812 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.85e-06 | 190 | 193 | 8 | a90a38fccdbf75a286b4d258fc54920c02b282f7 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-06 | 191 | 193 | 8 | 1924af7d8b0a0b892e480a9fd6d874941b0c0b5d | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-06 | 191 | 193 | 8 | 88f91e57a1409bdeb91e9bf47510a6fb998a1bf5 | |
| ToppCell | ILEUM-inflamed-(1)_T_cell-(1)_Th17_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.00e-06 | 192 | 193 | 8 | 12f7ea575da5d650c740e6060f5dab0478e563dd | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.00e-06 | 192 | 193 | 8 | d525f7f088a53110912600a7c9f6d33b9270d534 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.00e-06 | 192 | 193 | 8 | 6806a1a9fe00395dc1abc3e0124b4261dc701f31 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.00e-06 | 192 | 193 | 8 | 2bfac6b3956265205ca47d06888851ed68b65999 | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 2.00e-06 | 192 | 193 | 8 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | facs-Liver-Non-hepatocytes-3m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-06 | 193 | 193 | 8 | 8084fa0ce61f1f4a728423b6b81df04eaa5af5b6 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-06 | 194 | 193 | 8 | c8b9551b93a5aed62154b487db90130604a6125c | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-MGE2|World / Primary Cells by Cluster | 2.16e-06 | 194 | 193 | 8 | b42fd64b0fb95434a9e4e6586f31d26114a4074b | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-MGE2-10|World / Primary Cells by Cluster | 2.16e-06 | 194 | 193 | 8 | 81e7bc6516ab8d02ccd1c76a56a3533b788c27c8 | |
| ToppCell | 3'-Distal_airway|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.16e-06 | 194 | 193 | 8 | e9ff4398e880d13894e52c0ba9cf19a7662c248b | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-06 | 194 | 193 | 8 | a3adcdc8b87332e8beb9bcd70cf36424af10633d | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-06 | 195 | 193 | 8 | 12ba6d95e42d06b1991b011043c0e3370a7b4131 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-06 | 195 | 193 | 8 | 85df110f753f58ab017018c54ee454edb4428e29 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-06 | 195 | 193 | 8 | dd281a249854800f737dc22e0f375f66dfb5cf5f | |
| ToppCell | 3'-Distal_airway-Epithelial|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.24e-06 | 195 | 193 | 8 | 72fa2ba064055e2fee2b2cb8633c8f9a3c4373da | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-06 | 195 | 193 | 8 | 49c99553629cdd83ee56a2e508d5bc8d34b8507b | |
| ToppCell | Macrophages-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 2.33e-06 | 196 | 193 | 8 | 861c402ed8b8fde3582cc777c1357b45f5a2489b | |
| ToppCell | moderate-Lymphoid-Treg|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.33e-06 | 196 | 193 | 8 | 9152f4a8a27ff4ee28f231c5ad00eb2edd9ea6da | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.33e-06 | 196 | 193 | 8 | 5fe6534af65d43eeacd4b031310242b4f706008b | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.42e-06 | 197 | 193 | 8 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | distal-Hematologic-Platelet/Megakaryocyte|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.42e-06 | 197 | 193 | 8 | e28b1b154d9588dce07c123b36f7f01fa90a5fc1 | |
| ToppCell | medial-2-Hematologic-Interstitial_Macrophage|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.42e-06 | 197 | 193 | 8 | 38a74eeb2a4c8d6a86b133f02f4e6c641f16a3ac | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-G|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.42e-06 | 197 | 193 | 8 | a21a710c824f9e5c7ef1674168d1ce5aef85bd35 | |
| ToppCell | medial-Hematologic-Interstitial_Macrophage-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.42e-06 | 197 | 193 | 8 | b90c8a41e99c87b46be699d03cd49c97a2ad51af | |
| ToppCell | COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi|lung / Disease (COVID-19 only), tissue and cell type | 2.42e-06 | 197 | 193 | 8 | 3896729740d151f0eb845f1961c7b969bfbdd28d | |
| ToppCell | distal-3-Epithelial-Proximal_Ciliated|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.42e-06 | 197 | 193 | 8 | 15b4d1203943ce90a7083178d4a4284d9b323071 | |
| ToppCell | medial-Hematologic-Interstitial_Macrophage|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.42e-06 | 197 | 193 | 8 | 13aec816e21754eac590a12c3a9c795c41108277 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_other-Macro_CHIT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.51e-06 | 198 | 193 | 8 | 0b41b3d6c2db795320e8b65d40d85fb8b618cc34 | |
| ToppCell | LPS_only|World / Treatment groups by lineage, cell group, cell type | 2.61e-06 | 199 | 193 | 8 | 852cf595c2255983cff9045f2bb746d4391cf5ba | |
| ToppCell | cellseq2-Immune-Immune_Myeloid-IM-IM|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.61e-06 | 199 | 193 | 8 | 372fb9eb90022dc4ac770a75b4e207c33d1d0c43 | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.61e-06 | 199 | 193 | 8 | ef7f7f7c861827574b120f48cf4052c563929081 | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.61e-06 | 199 | 193 | 8 | 41f046646fff65b7e51b63d3204f76ef32054781 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.61e-06 | 199 | 193 | 8 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Skin|World / Skin and Kidney Cells in Lupus Nephritis Patients. | 2.61e-06 | 199 | 193 | 8 | 6be1340413ee868c610b6e3f58c65b493eb22bb5 | |
| ToppCell | cellseq2-Immune-Immune_Myeloid-IM|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.61e-06 | 199 | 193 | 8 | dd3bf59cdc18091889cbf6c43f37100ba537843d | |
| ToppCell | cellseq2-Immune-Immune_Myeloid|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.61e-06 | 199 | 193 | 8 | 6c3c9eceea20121ae17ae2462134aa0437f591b3 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.61e-06 | 199 | 193 | 8 | 379bbd9cecf466b902411c54d74bd9885285b1ba | |
| ToppCell | mLN-Macrophage-LYVE1_Macrophage|Macrophage / Region, Cell class and subclass | 2.71e-06 | 200 | 193 | 8 | e3c15e0e1c2602b0cc9ab8cc50c978d265350c94 | |
| ToppCell | distal-3-Hematologic-Platelet/Megakaryocyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.71e-06 | 200 | 193 | 8 | f5f5a8b0e4d802d95dc42646dd5e7d7daaad72b4 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.71e-06 | 200 | 193 | 8 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.71e-06 | 200 | 193 | 8 | 2554b77edfe3d378296b0b25625caacbfb1c0e76 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.71e-06 | 200 | 193 | 8 | 918b576fd9491d23c2bb9d663fa5fb3505cb1c7e | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.71e-06 | 200 | 193 | 8 | 26df6ac63710655604888c3be6509b6c4befc0be | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_ciliated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.71e-06 | 200 | 193 | 8 | 5abd6d81e1cc354484ae693fcd708d78926e75b5 | |
| ToppCell | Skin-Keratinocytes|Skin / Skin and Kidney Cells in Lupus Nephritis Patients. | 2.71e-06 | 200 | 193 | 8 | 59d72395199bc30df0e811fbc99149694e208860 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_ciliated-Ciliated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.71e-06 | 200 | 193 | 8 | 9c9d2b0276c7b0709c2eeeb0673a2f58106fb14e | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.71e-06 | 200 | 193 | 8 | ddd39b754bfaa98249d497dfb7e97ec58617a11a | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 2.71e-06 | 200 | 193 | 8 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-Ciliated|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 2.71e-06 | 200 | 193 | 8 | a521cf837cadf280505ff9d7e641a205af7d6513 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.71e-06 | 200 | 193 | 8 | 07819a90ac347883b78d0bb3cd8c5eb0d66e1e22 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 5.44e-06 | 156 | 193 | 7 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Macrophage|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.92e-06 | 158 | 193 | 7 | 1635a85fc73c544028418087f36d28957dd4f458 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Macrophage-macrophage,_alveolar|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.92e-06 | 158 | 193 | 7 | 80841dadfa53bcde36a3e486408a095f78e772eb | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.43e-06 | 160 | 193 | 7 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.43e-06 | 160 | 193 | 7 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.43e-06 | 160 | 193 | 7 | 18954241e11309ecb0f3ca87897eadcb20dc8eca | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Glra3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.43e-06 | 160 | 193 | 7 | 0bfdaf979e6f128cba2928ce16bca4d3deff8ac9 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.69e-06 | 161 | 193 | 7 | 5a8698790f9aba796dd2b64af419055c60bd7de8 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.97e-06 | 162 | 193 | 7 | 9d6931619f5eb847c79d00ff5ae031fef30fd55c | |
| ToppCell | PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.86e-06 | 165 | 193 | 7 | 6799a6580c667738995cceb31cbf1c7fbdc4ff84 | |
| ToppCell | NS-critical-d_0-4-Epithelial-unknown_epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.18e-06 | 166 | 193 | 7 | dd02bbe4af609c6348dc92417254f4740f2900a8 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-8|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 8.84e-06 | 168 | 193 | 7 | 00646601548b0fee42ae16bfa5e93603bc7c5129 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.92e-06 | 171 | 193 | 7 | 6e7ade1d14a3ec4c566476aac3eb509bd2661e39 | |
| ToppCell | PND10-Immune-Immune_Myeloid|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.92e-06 | 171 | 193 | 7 | 36b24c417b7af9aa16a841b20bba98a74de320b6 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-05 | 172 | 193 | 7 | 1b133be191252e7053faeacf9547730c3ae28d21 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-05 | 172 | 193 | 7 | b3c53fd7e50f36de6a8585ae21d04e17932f262c | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-05 | 173 | 193 | 7 | 869da6a65d1b9b7529c666ec44e3c8ddec2ea408 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-05 | 173 | 193 | 7 | 0672bd8a4a9d18af343d01f09253fb3388896c10 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-05 | 173 | 193 | 7 | 870e091ec30be01a900e1cb8b9ef1880e3b7b50d | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c5-CD16|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.15e-05 | 175 | 193 | 7 | dc7721794162dee96944f4b4b87b5681bb02ea8f | |
| ToppCell | Children_(3_yrs)-Immune-enucleated_erythrocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.15e-05 | 175 | 193 | 7 | 36cb3c8116bd467ee5da0630d8b3d3e4afcc2ded | |
| ToppCell | LPS-IL1RA+antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.24e-05 | 177 | 193 | 7 | b7fee75de7e96924af488a5baa2334711889ae7c | |
| Drug | plakin | 4.27e-07 | 82 | 190 | 8 | CID000018752 | |
| Drug | Flumequine [42835-25-6]; Up 200; 15.4uM; MCF7; HT_HG-U133A | 6.45e-06 | 197 | 190 | 10 | 2276_UP | |
| Drug | Biperiden hydrochloride [1235-82-1]; Down 200; 11.4uM; MCF7; HT_HG-U133A | CACNA2D2 BRINP1 ITGA2B RASIP1 UTRN DTNA APC NLGN1 ADAMTS12 CROCC | 7.06e-06 | 199 | 190 | 10 | 5644_DN |
| Drug | Florfenicol [73231-34-2]; Up 200; 11.2uM; PC3; HT_HG-U133A | 7.37e-06 | 200 | 190 | 10 | 6701_UP | |
| Drug | cathepsin C substrate | 1.12e-05 | 6 | 190 | 3 | CID003508173 | |
| Disease | cerebral palsy (implicated_via_orthology) | 1.19e-11 | 10 | 186 | 6 | DOID:1969 (implicated_via_orthology) | |
| Disease | Limb-girdle muscular dystrophy | 2.05e-05 | 26 | 186 | 4 | cv:C0686353 | |
| Disease | autosomal recessive nonsyndromic deafness 16 (implicated_via_orthology) | 3.95e-05 | 2 | 186 | 2 | DOID:0110471 (implicated_via_orthology) | |
| Disease | phospholipids:total lipids ratio, intermediate density lipoprotein measurement | 6.64e-05 | 67 | 186 | 5 | EFO_0008595, EFO_0020946 | |
| Disease | alkaline phosphatase measurement | DLG5 ACAP1 AGPAT5 RASIP1 NWD2 ATRIP NLGN2 UTRN HOMEZ CA11 APOE LCP1 ZNF45 TREH ASL MACF1 AKAP13 | 2.53e-04 | 1015 | 186 | 17 | EFO_0004533 |
| Disease | cholesteryl esters to total lipids in small VLDL percentage | 2.59e-04 | 49 | 186 | 4 | EFO_0022256 | |
| Disease | polyunsaturated fatty acids to monounsaturated fatty acids ratio | 3.03e-04 | 51 | 186 | 4 | EFO_0022302 | |
| Disease | focal segmental glomerulosclerosis 1 (implicated_via_orthology) | 3.90e-04 | 5 | 186 | 2 | DOID:0111128 (implicated_via_orthology) | |
| Disease | nuclear receptor-binding protein measurement | 3.90e-04 | 5 | 186 | 2 | EFO_0801854 | |
| Disease | angiomyolipoma (is_marker_for) | 3.90e-04 | 5 | 186 | 2 | DOID:3314 (is_marker_for) | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 3.91e-04 | 150 | 186 | 6 | EFO_0004611, EFO_0020947 | |
| Disease | Headache, type 2 diabetes mellitus | 3.98e-04 | 23 | 186 | 3 | HP_0002315, MONDO_0005148 | |
| Disease | serum albumin measurement | AGPAT5 DCST1 SVEP1 PLEC MRC1 APOE AAGAB YWHAB MACF1 RORA PCNT TEDC1 | 4.02e-04 | 592 | 186 | 12 | EFO_0004535 |
| Disease | low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 4.34e-04 | 153 | 186 | 6 | EFO_0004611, EFO_0020946 | |
| Disease | pulse pressure measurement | MYH6 NCKAP1 SETD6 ACTN4 FAM186B SVEP1 RCOR2 STAT3 ULK4 VCL HOMEZ KDM5A TRIOBP LAMA5 APOE LCP1 ANKDD1A AKAP13 SLC2A13 HYDIN | 5.27e-04 | 1392 | 186 | 20 | EFO_0005763 |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 5.43e-04 | 222 | 186 | 7 | EFO_0008317, EFO_0020943 | |
| Disease | phospholipids in chylomicrons and extremely large VLDL measurement | 6.81e-04 | 63 | 186 | 4 | EFO_0022292 | |
| Disease | Bipolar Disorder | RAPGEF5 TRPM2 STARD9 ULK4 CACNA1B NLGN1 APOE TSPAN8 RORA PCNT | 9.47e-04 | 477 | 186 | 10 | C0005586 |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, esterified cholesterol measurement | 1.08e-03 | 8 | 186 | 2 | EFO_0008317, EFO_0008589, EFO_0008596 | |
| Disease | body fat percentage | 1.12e-03 | 488 | 186 | 10 | EFO_0007800 | |
| Disease | nephroblastoma (is_marker_for) | 1.28e-03 | 34 | 186 | 3 | DOID:2154 (is_marker_for) | |
| Disease | intellectual disability (implicated_via_orthology) | 1.31e-03 | 75 | 186 | 4 | DOID:1059 (implicated_via_orthology) | |
| Disease | response to clopidogrel, response to acetylsalicylate, major adverse cardiovascular event measurement | 1.38e-03 | 9 | 186 | 2 | EFO_0020863, GO_1903492, GO_1903493 | |
| Disease | diacylglycerol 36:4 measurement | 1.38e-03 | 9 | 186 | 2 | EFO_0020063 | |
| Disease | Cardiomyopathies | 1.43e-03 | 130 | 186 | 5 | C0878544 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 1.49e-03 | 264 | 186 | 7 | EFO_0008317, EFO_0020944 | |
| Disease | Schizophrenia | SPTBN2 ULK4 PPP1R9B NLGN2 MED12 CNP CACNA1B APC NLGN1 APOE ADAMTS12 TSPAN8 IL3RA PCNT | 1.50e-03 | 883 | 186 | 14 | C0036341 |
| Disease | Duchenne muscular dystrophy (implicated_via_orthology) | 1.51e-03 | 36 | 186 | 3 | DOID:11723 (implicated_via_orthology) | |
| Disease | cholesterol in small HDL measurement | 1.51e-03 | 36 | 186 | 3 | EFO_0022226 | |
| Disease | cholesteryl esters to total lipids in very large HDL percentage | 1.51e-03 | 36 | 186 | 3 | EFO_0022257 | |
| Disease | monounsaturated fatty acids; 16:1, 18:1 measurement | 1.52e-03 | 78 | 186 | 4 | EFO_0022187 | |
| Disease | cholesteryl esters to total lipids in medium LDL percentage | 1.64e-03 | 37 | 186 | 3 | EFO_0022252 | |
| Disease | cystic kidney disease (implicated_via_orthology) | 1.72e-03 | 10 | 186 | 2 | DOID:2975 (implicated_via_orthology) | |
| Disease | Muscular dystrophy, limb-girdle, autosomal dominant | 1.72e-03 | 10 | 186 | 2 | cv:C5675009 | |
| Disease | oleoyl-linoleoyl-glycerol (18:1/18:2) [2] measurement | 1.72e-03 | 10 | 186 | 2 | EFO_0800333 | |
| Disease | temporomandibular joint disorder | 1.72e-03 | 10 | 186 | 2 | EFO_0005279 | |
| Disease | degree of unsaturation measurement | 1.91e-03 | 39 | 186 | 3 | EFO_0022261 | |
| Disease | docosahexaenoic acid measurement, fatty acid measurement | 2.05e-03 | 40 | 186 | 3 | EFO_0005110, EFO_0007761 | |
| Disease | oleoyl-linoleoyl-glycerol (18:1/18:2) [1] measurement | 2.09e-03 | 11 | 186 | 2 | EFO_0800332 | |
| Disease | Anorectal Malformations | 2.20e-03 | 41 | 186 | 3 | C3495676 | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 2.24e-03 | 144 | 186 | 5 | EFO_0004611, EFO_0020943 | |
| Disease | phosphatidylcholine measurement | 2.25e-03 | 284 | 186 | 7 | EFO_0010226 | |
| Disease | descending aortic diameter | 2.36e-03 | 88 | 186 | 4 | EFO_0021788 | |
| Disease | integral membrane protein 2B measurement | 2.50e-03 | 12 | 186 | 2 | EFO_0802634 | |
| Disease | lymphangioleiomyomatosis (is_marker_for) | 2.50e-03 | 12 | 186 | 2 | DOID:3319 (is_marker_for) | |
| Disease | dilated cardiomyopathy (is_implicated_in) | 2.53e-03 | 43 | 186 | 3 | DOID:12930 (is_implicated_in) | |
| Disease | triacylglycerol 56:6 measurement | 2.53e-03 | 43 | 186 | 3 | EFO_0010433 | |
| Disease | free cholesterol to total lipids in IDL percentage | 2.53e-03 | 43 | 186 | 3 | EFO_0022278 | |
| Disease | cholesteryl esters to total lipids in small HDL percentage | 2.53e-03 | 43 | 186 | 3 | EFO_0022254 | |
| Disease | immunoglobulin isotype switching measurement | 2.70e-03 | 44 | 186 | 3 | EFO_0010128 | |
| Disease | Familial dilated cardiomyopathy | 2.70e-03 | 44 | 186 | 3 | C0340427 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.83e-03 | 152 | 186 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | total lipids in very small VLDL measurement | 2.88e-03 | 45 | 186 | 3 | EFO_0022156 | |
| Disease | IGFBP-1 measurement | 2.95e-03 | 13 | 186 | 2 | EFO_0005118 | |
| Disease | human Chorionic Gonadotropin measurement | 2.95e-03 | 13 | 186 | 2 | EFO_0008156 | |
| Disease | DEAFNESS, AUTOSOMAL RECESSIVE (disorder) | 2.95e-03 | 13 | 186 | 2 | C1846647 | |
| Disease | gallbladder cancer (is_implicated_in) | 2.95e-03 | 13 | 186 | 2 | DOID:3121 (is_implicated_in) | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 3.13e-03 | 225 | 186 | 6 | EFO_0008317, EFO_0020947 | |
| Disease | platelet component distribution width | SIRPA ITGA2B SVEP1 PPP1R9B PLEC LAMA5 ABCC5 APOE LCP1 ANKDD1A MACF1 AKAP13 | 3.16e-03 | 755 | 186 | 12 | EFO_0007984 |
| Disease | chylomicron measurement, triglyceride measurement, very low density lipoprotein cholesterol measurement | 3.23e-03 | 96 | 186 | 4 | EFO_0004530, EFO_0008317, EFO_0008596 | |
| Disease | free cholesterol in very small VLDL measurement | 3.26e-03 | 47 | 186 | 3 | EFO_0022275 | |
| Disease | phospholipids:total lipids ratio | 3.27e-03 | 227 | 186 | 6 | EFO_0020946 | |
| Disease | cholesterol efflux capacity measurement | 3.42e-03 | 14 | 186 | 2 | EFO_0009132 | |
| Disease | membranous glomerulonephritis (biomarker_via_orthology) | 3.42e-03 | 14 | 186 | 2 | DOID:10976 (biomarker_via_orthology) | |
| Disease | revision of total hip arthroplasty | 3.42e-03 | 14 | 186 | 2 | EFO_0020973 | |
| Disease | Autosomal recessive limb-girdle muscular dystrophy | 3.42e-03 | 14 | 186 | 2 | cv:C2931907 | |
| Disease | Malignant neoplasm of breast | ACAP1 CTU2 SPTAN1 CTIF STAT1 STAT3 BMP2 DMD DNAH9 MED12 ANK1 ASL MACF1 ZFYVE26 TOP2A | 3.45e-03 | 1074 | 186 | 15 | C0006142 |
| Disease | hearing impairment | 3.48e-03 | 98 | 186 | 4 | C1384666 | |
| Disease | polyunsaturated fatty acids to total fatty acids percentage | 3.89e-03 | 50 | 186 | 3 | EFO_0022303 | |
| Disease | cholesteryl esters to total lipids in IDL percentage | 3.89e-03 | 50 | 186 | 3 | EFO_0022247 | |
| Disease | low density lipoprotein triglyceride measurement | 3.93e-03 | 15 | 186 | 2 | EFO_0009946 | |
| Disease | head and neck squamous cell carcinoma (is_implicated_in) | 3.93e-03 | 15 | 186 | 2 | DOID:5520 (is_implicated_in) | |
| Disease | Myopia | 3.93e-03 | 15 | 186 | 2 | C0027092 | |
| Disease | cholesterol to total lipids in small HDL percentage | 4.11e-03 | 51 | 186 | 3 | EFO_0022240 | |
| Disease | cholesterol to total lipids in small VLDL percentage | 4.11e-03 | 51 | 186 | 3 | EFO_0022242 | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 4.16e-03 | 103 | 186 | 4 | EFO_0008595, EFO_0020944 | |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 4.20e-03 | 239 | 186 | 6 | EFO_0008317, EFO_0020945 | |
| Disease | cerebellar volume measurement | 4.34e-03 | 52 | 186 | 3 | EFO_0020864 | |
| Disease | Parkinson disease | 4.40e-03 | 321 | 186 | 7 | MONDO_0005180 | |
| Disease | cholesteryl esters to total lipids in very large VLDL percentage | 4.58e-03 | 53 | 186 | 3 | EFO_0022258 | |
| Disease | cholesterol to total lipids in very large VLDL percentage | 4.83e-03 | 54 | 186 | 3 | EFO_0022244 | |
| Disease | Lipidemias | 5.05e-03 | 17 | 186 | 2 | C1706412 | |
| Disease | lateral occipital cortex volume measurement | 5.05e-03 | 17 | 186 | 2 | EFO_0010311 | |
| Disease | Hyperlipidemia | 5.05e-03 | 17 | 186 | 2 | C0020473 | |
| Disease | cholesterol to total lipids in large HDL percentage | 5.08e-03 | 55 | 186 | 3 | EFO_0022234 | |
| Disease | phospholipids in medium HDL measurement | 5.08e-03 | 55 | 186 | 3 | EFO_0022295 | |
| Disease | cortical surface area measurement | RAPGEF5 ACTN4 SVEP1 STAT1 BMP2 PPP1R9B AGAP3 DPP4 APC TRIOBP GK5 DENND1A NR2F2 ZNF106 TREH MACF1 RORA | 5.15e-03 | 1345 | 186 | 17 | EFO_0010736 |
| Disease | Colorectal Carcinoma | ACAP1 SPTBN2 BRINP1 BMP2 MCM3AP TMEM164 DMD RBP3 APC ABCC5 SETD4 | 5.15e-03 | 702 | 186 | 11 | C0009402 |
| Disease | vital capacity | KNTC1 CACNA2D2 SPTBN2 CTIF ACTN3 SVEP1 UTRN VWA5B1 AGAP3 BEST1 CYP26B1 TENT5A AAGAB ZNF106 LRPAP1 RORA | 5.27e-03 | 1236 | 186 | 16 | EFO_0004312 |
| Disease | triglycerides to total lipids in medium HDL percentage | 5.35e-03 | 56 | 186 | 3 | EFO_0022333 | |
| Disease | triglycerides in chylomicrons and extremely large VLDL measurement | 5.35e-03 | 56 | 186 | 3 | EFO_0022316 | |
| Disease | cholesteryl esters to total lipids in medium HDL percentage | 5.35e-03 | 56 | 186 | 3 | EFO_0022251 | |
| Disease | Adrenocortical carcinoma | 5.66e-03 | 18 | 186 | 2 | C0206686 | |
| Disease | triacylglycerol 56:3 measurement | 5.66e-03 | 18 | 186 | 2 | EFO_0010430 | |
| Disease | diacylglycerol 36:3 measurement | 5.66e-03 | 18 | 186 | 2 | EFO_0020062 | |
| Disease | very low density lipoprotein cholesterol measurement, esterified cholesterol measurement | 5.66e-03 | 18 | 186 | 2 | EFO_0008317, EFO_0008589 | |
| Disease | low density lipoprotein particle size measurement | 5.90e-03 | 58 | 186 | 3 | EFO_0008593 | |
| Disease | triglycerides to total lipids in small VLDL percentage | 5.90e-03 | 58 | 186 | 3 | EFO_0022338 | |
| Disease | total lipids in medium HDL measurement | 5.90e-03 | 58 | 186 | 3 | EFO_0022310 | |
| Disease | cholesterol in medium HDL measurement | 6.18e-03 | 59 | 186 | 3 | EFO_0021903 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LRVLEAETQILTDWQ | 61 | O75528 | |
| QDWDQTVETAQRLLL | 226 | Q7Z4L5 | |
| ETNWCIDRNLQVSLL | 306 | Q8N1M1 | |
| EERDAWVQAIQSQIL | 406 | Q96P64 | |
| EERELWVQSVQAQIL | 591 | Q96P47 | |
| QLLRDNLTLWTSENQ | 221 | P31946 | |
| QLWSVVGDEVVLINR | 871 | Q92667 | |
| RLTEEVQWLRLSLQE | 86 | Q96LX7 | |
| LANQINDLRQSVTWL | 346 | Q9NX77 | |
| DAWVQAIQSQILASL | 296 | Q8TF27 | |
| RDAWVQAIQSQILAS | 476 | Q5VTM2 | |
| RWVQTLSEQVQEELL | 56 | P02649 | |
| LALINNIVEIRVDAW | 696 | Q75V66 | |
| TVREELQQQDVERWL | 461 | O43310 | |
| ILDTGITQQLVERVW | 731 | Q9NY47 | |
| ITQQLVERVWRDQDL | 736 | Q9NY47 | |
| ERTIQQWLARVQSLL | 381 | O60477 | |
| QLLRDNLTLWTADNA | 221 | P31947 | |
| NSLLEQSVALLNLWV | 1441 | P16157 | |
| QSVALLNLWVIREGQ | 1446 | P16157 | |
| QTQAVLRQAWLENIR | 126 | Q7Z2Z2 | |
| ELLWQLLQRSDLVLQ | 211 | A6NE02 | |
| RNSWIQIIQDTINTL | 2321 | Q12802 | |
| WEQLLTTIARTINEV | 736 | O43707 | |
| TLLLLSTQNWNRVEA | 11 | Q9C0A0 | |
| ETNWIVDRNLQVSLL | 306 | O76090 | |
| QADSERLLQLWVSAV | 341 | Q15027 | |
| QIREQAQELGVLLSW | 336 | Q8N283 | |
| TWILIDRALNITSLQ | 251 | O75493 | |
| QDNRLLTATDSIQLW | 121 | Q8TDJ6 | |
| ENIDRLQSLRLQAWT | 751 | Q8IYM0 | |
| EQLNSRWIEFCQLLS | 806 | P11532 | |
| SVQWVSVVSLQLLLE | 121 | Q9HCK5 | |
| VTLENLLTWQARQRT | 266 | P78325 | |
| RVIDLWDLAQSANLT | 256 | P30533 | |
| EAAALNAVQRLEWQL | 2011 | Q6UB98 | |
| VLECERNQTLVQTAW | 211 | Q9UK58 | |
| LLDTRLVNQNASRWE | 191 | P12643 | |
| EVLIRELWNTNLLQT | 276 | Q96AQ1 | |
| EVLIRELWNTNLLQT | 276 | Q96LY2 | |
| SVWEQRASQLRLQNL | 766 | Q00975 | |
| WLNRAQNISILTVCE | 336 | Q8N608 | |
| RSWLANLSVVAQLLN | 6 | P58397 | |
| EERDAWVQAIQSQIL | 406 | Q5VW22 | |
| QEARRLGLITQEQWQ | 146 | Q149M9 | |
| ISTWDVETRQLLRQI | 991 | Q9ULI1 | |
| ITQVLNFWNLLSEIE | 811 | Q09MP3 | |
| RWTTDEQLLAVQAIR | 331 | Q8IZ40 | |
| INARWTTEEQLLAVQ | 286 | Q9P2K3 | |
| RAVQIRTNLDLVLDW | 801 | Q5U651 | |
| LQEVLAQLRWQTDGE | 166 | A6NNM3 | |
| LQEVLAQLRWQTDGE | 166 | A6NJZ7 | |
| LQITDQVALLRLTWS | 236 | P24468 | |
| AIQVVRSALANQIDW | 361 | O60524 | |
| LILSSRQDNTEELWL | 36 | Q96QG7 | |
| DRLQQFIQVLLEESW | 6 | P60608 | |
| SSVDWQIRQVRALLQ | 446 | P04424 | |
| SVTLLLAVSQQLWQL | 21 | Q9NR63 | |
| SWEQARLQTQKELQL | 1791 | O60318 | |
| VQALEQRNQLLETRW | 101 | Q6KB66 | |
| QWTLEIQDLPSQVRN | 601 | P29122 | |
| VNDDIIVNWVNETLR | 516 | P13796 | |
| LENERSINLLTWTLQ | 271 | O14524 | |
| TWQLSALAEQQRRIL | 191 | A8MZ36 | |
| ALAEQQRRILQQDWS | 196 | A8MZ36 | |
| ALAEQQRRILQQDWS | 241 | Q92817 | |
| VNDWLLRINDVDLIN | 671 | Q8TDM6 | |
| AQWSTLVQELEAALQ | 421 | Q8WVB3 | |
| LLNEATRWSSAIQNV | 1481 | Q9HD67 | |
| ARALQQNTSLEILWL | 861 | Q9Y239 | |
| QNTSLEILWLTQNEL | 866 | Q9Y239 | |
| IQWAETTLIQRDQEP | 3021 | O94854 | |
| TRQLVTRQDEWGQLL | 336 | A0A1B0GTW7 | |
| NLQESSQWELALRFV | 1261 | P50748 | |
| LDQWTMRQSSLELQL | 1351 | Q93074 | |
| QLITEERIPNNTQWV | 141 | P27487 | |
| CRLETILAWQQQLQD | 201 | Q8TCJ0 | |
| QNLRTLWIEANCLTQ | 121 | Q5BKY1 | |
| QRLLARVQEQLSSLW | 2346 | O15230 | |
| RVQEQLSSLWEENQA | 2351 | O15230 | |
| SVILSEVQRNLNSWD | 911 | Q86UT6 | |
| LLDLIQALRWTSENI | 271 | Q8N2Q7 | |
| AQSQEEIRRLWSQLD | 461 | O95613 | |
| QELQQARWLDEVRLT | 896 | P29375 | |
| ADQWRNAQLLSLISA | 221 | Q9Y2A7 | |
| NLSQRDLAISINFWV | 956 | Q13349 | |
| DQQLVLVRNCWASLL | 281 | P51843 | |
| AWTQAVSLEVLDLRN | 531 | Q14392 | |
| ANLSQAELVDLVQWT | 276 | Q86VR8 | |
| LRFLEQLSILQTWQQ | 16 | Q86WN1 | |
| QLSILQTWQQREADL | 21 | Q86WN1 | |
| QAWILNATLRDNILF | 631 | O15440 | |
| DLEAWRFLVILQLVQ | 276 | Q9HDB9 | |
| WRELEAERAQLQSQL | 1006 | Q5TZA2 | |
| AQQLTWDLNRNVTDI | 36 | P26951 | |
| RNDLNNWVAEEILAI | 1131 | Q4G0P3 | |
| TVTETNQEWQVLQLR | 841 | O14981 | |
| FQDRWNQLDLAIVLL | 1671 | O43497 | |
| VELQINNTRAAWRIS | 151 | Q5T197 | |
| TRALQDSWLQAQAVL | 1921 | Q9BV73 | |
| TDLNLVQALRQFLWS | 136 | Q99418 | |
| PQRAWTVEQLRSEQL | 6 | Q00688 | |
| QLRQEWENNRESLIT | 361 | O75976 | |
| EERDAWVQAIQSQIL | 406 | Q5VUJ5 | |
| TGARVELSEQQLQLW | 296 | P09543 | |
| WEQEIRLTEQAVQAI | 61 | Q9BRF8 | |
| QDQWLDEQLSIARQR | 181 | Q9BRF8 | |
| SNILQRWDEICQALL | 321 | A0A1W2PPF3 | |
| TKRQENQWNELLETL | 121 | Q8TEH3 | |
| WNVIEALRENALNNL | 56 | Q9Y4J8 | |
| QQTSLRLVWILQNLT | 166 | Q6ZS86 | |
| QLLRQSLNTISQEWF | 771 | Q5T7N3 | |
| NLDVLLVASWQELSR | 231 | A4GXA9 | |
| EERWQRLQSQVISEL | 671 | Q9BXX0 | |
| VQSWELLTQTLVEAL | 2771 | Q9NYC9 | |
| LQLVWTQAAQTSELD | 51 | Q8IX15 | |
| VALETQWLQLEQEVV | 646 | Q8WXE1 | |
| VTWLNRAQNVSILTL | 396 | P42658 | |
| LEANEIVSLLTWVLN | 331 | O60645 | |
| VVINRSLVLTGQWEA | 156 | Q9Y315 | |
| QSLVQLEATEWRLRS | 251 | Q6NYC8 | |
| LDQIQALRWLSENIA | 236 | Q8NFZ4 | |
| LTRNDWRVASELINI | 591 | Q9NXZ2 | |
| WRVASELINILERAN | 596 | Q9NXZ2 | |
| EAQLRTQRAWGLQEI | 486 | Q2VPK5 | |
| IWAVLNQSAESLQEL | 21 | Q12923 | |
| LWINAAATEVVNILR | 431 | Q6J4K2 | |
| ERVWIALNSNLTDNQ | 1151 | P22897 | |
| RQLSLDALWQELLVS | 111 | Q96QE2 | |
| DQVQRCIWFQQLLLS | 486 | Q8NHP6 | |
| VQNVDLVLAVWDRSL | 321 | Q8NBV8 | |
| STWQELRQLQEQIRS | 91 | Q9NP81 | |
| QLQQLSAWLTLTEER | 426 | P46939 | |
| NWFTIVAESLQQVRQ | 261 | P42224 | |
| IHRRWVLQQLIQETS | 141 | Q7Z6K3 | |
| LWLQNFVRILLNEED | 91 | Q6XZB0 | |
| LQEVLAQLRWQTDGE | 166 | Q9UFD9 | |
| VTVQLQNGEIWELSR | 86 | Q86VW1 | |
| WLVTVLHDRQINLNE | 61 | A6NEY8 | |
| LSLLLQRCNEVQLWV | 386 | Q92565 | |
| QRCNEVQLWVATEIL | 391 | Q92565 | |
| ALINQLTLVESLWTE | 406 | Q9NVD3 | |
| SWRQLLQNSVLLTLQ | 411 | Q8TBK2 | |
| QRLQLTWLENGNVSR | 281 | P78324 | |
| EARVLRNETNNQTIW | 41 | Q9UIF3 | |
| TWLLQAAQLRLSQEE | 281 | Q9BR26 | |
| QCLLREETWLASLQQ | 691 | Q9P2P6 | |
| QVWTQLLRALEERAI | 981 | P08514 | |
| IVERRDALLVIQWNI | 806 | P13533 | |
| WENQQRLLQTLETIT | 936 | Q4LDE5 | |
| WTLNIVNLRCETQDI | 181 | Q8N1H7 | |
| LLLEGTRWQALVQVQ | 181 | Q7RTU9 | |
| EVQALRAQLEAWRLQ | 2071 | Q9H2D6 | |
| REQLQSIQAQWTRLQ | 1286 | Q9NRC6 | |
| LNNIETTWNSFIRIL | 251 | Q15399 | |
| RIVQALNANVWSNVV | 161 | Q6PD74 | |
| QETQQLRSVLWRLAS | 406 | Q495B1 | |
| WEQLLTSIARTINEV | 731 | Q08043 | |
| RDAWVQAIQSQILAS | 431 | A6NIR3 | |
| QQVIASVLRNLSWRA | 541 | P25054 | |
| WDREILLNILTLFEN | 381 | Q9P291 | |
| QELSLIVTLWNLTLQ | 86 | Q6UXG3 | |
| QEQRNLLLDLLSTWT | 366 | Q8NCG5 | |
| RNLNRETNIIGTWEV | 156 | I1YAP6 | |
| DRTVRIWDLATLQQL | 721 | Q96KV7 | |
| LVQIWALQEASSLSV | 11 | Q96BF3 | |
| RLVWQQLVDTAALVI | 766 | P10745 | |
| ELLQWIEQTIVTLND | 316 | O15020 | |
| LREELQQITWQTFLQ | 291 | P35398 | |
| AFLSWQQRLLESVVV | 31 | Q5U3C3 | |
| WITSLAESQLQTRQQ | 266 | P40763 | |
| VQNRRELAGIIWAQS | 631 | O94759 | |
| LQDERWQDLNVISSL | 966 | Q9P227 | |
| REELITNWEQIRTLA | 336 | Q13813 | |
| TLERENQRLEAVLAW | 301 | Q86SX3 | |
| SQRLAALNTVLWDEQ | 381 | O43280 | |
| INEIIRVLQLTSWDE | 241 | P18206 | |
| LAEAQLRFIQAWQSL | 536 | Q86UX7 | |
| ILQEVQVITLENWET | 506 | Q86WI1 | |
| ERVAQLLERWQAVLA | 1316 | Q15149 | |
| LLERWQAVLAQTDVR | 1321 | Q15149 | |
| NLNRLQWVQLVDLTE | 196 | Q9UKN8 | |
| VHAWEISDQLLQIRQ | 41 | Q9Y5L0 | |
| RVTIDPENNLISIWN | 106 | P11388 | |
| QRAWIPSENIQDITV | 316 | Q15326 | |
| INDSLLVWLQVIVAN | 296 | Q7Z5H4 | |
| QQLIRETLISWLQAQ | 76 | O43592 | |
| LFLQDQAQRLTEWLQ | 16 | P0C7M3 | |
| LLLEGTRWQALVQVQ | 181 | A6NGW2 | |
| DSALLRTQWDLTNIQ | 266 | O95900 | |
| RTQWDLTNIQDAIRA | 271 | O95900 | |
| IDLLQRFRLWNVSNE | 681 | Q96S15 | |
| QILISRELLVDQNLW | 1661 | Q9BXT5 | |
| TVDWIVADILAIRQN | 96 | Q9NUQ2 | |
| LRAELWALILNISSQ | 256 | Q8N5T2 | |
| LNWEQVQRLDGILSE | 66 | Q96IP4 | |
| VDWATVAVQTLQQLL | 1691 | Q68DK2 | |
| INNATLFQDEINWRL | 131 | P51784 | |
| RLLQHEWEESNVQIL | 1876 | O60293 | |
| ELFCSQIWQQITREL | 101 | Q02386 | |
| ILNASRRNVNWEQVI | 781 | Q9H2Y7 | |
| ELRLAVAWNRVDIAQ | 396 | Q8TD43 | |
| WQLQDLSFQTAARIL | 321 | Q9NYU2 | |
| ENTQISRAIWAALQT | 806 | Q9NYU2 | |
| ILALAIWVRVSNDSQ | 26 | P19075 | |
| LVSLVQSQNVEWRLF | 936 | Q96C45 | |
| QSQNVEWRLFSLRLL | 941 | Q96C45 | |
| TNQTSLDVQRWQIDL | 696 | Q5TIE3 | |
| RLSSVQQILQLSDLW | 416 | Q8IYS2 | |
| QQILQLSDLWRLTLQ | 421 | Q8IYS2 | |
| LQTLDLRNNEISWAI | 361 | O94898 | |
| VAQLIQQTLEQERWQ | 591 | Q96SB3 |